Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs
Dual maintenance therapy with atazanavir plus raltegravir sustains viral suppression
Once-daily Kaletra approved in the European Union
Boosted protease inhibitor regimens with 3TC work despite M184V resistance
Maturation inhibitor bevirimat is well tolerated and effective in predicted responders
Mental health and HIV: a clinical review
